These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 36278408)

  • 1. SCF
    O'Brien S; Kelso S; Steinhart Z; Orlicky S; Mis M; Kim Y; Lin S; Sicheri F; Angers S
    EMBO Rep; 2022 Dec; 23(12):e55044. PubMed ID: 36278408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SCF(FBXW7)-mediated degradation of p53 promotes cell recovery after UV-induced DNA damage.
    Galindo-Moreno M; Giráldez S; Limón-Mortés MC; Belmonte-Fernández A; Reed SI; Sáez C; Japón MÁ; Tortolero M; Romero F
    FASEB J; 2019 Oct; 33(10):11420-11430. PubMed ID: 31337255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The FBXW7-NOTCH interactome: A ubiquitin proteasomal system-induced crosstalk modulating oncogenic transformation in human tissues.
    Kar R; Jha SK; Ojha S; Sharma A; Dholpuria S; Raju VSR; Prasher P; Chellappan DK; Gupta G; Kumar Singh S; Paudel KR; Hansbro PM; Kumar Singh S; Ruokolainen J; Kesari KK; Dua K; Jha NK
    Cancer Rep (Hoboken); 2021 Aug; 4(4):e1369. PubMed ID: 33822486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer-associated FBXW7 loss is synthetic lethal with pharmacological targeting of CDC7.
    Baxter JS; Brough R; Krastev DB; Song F; Sridhar S; Gulati A; Alexander J; Roumeliotis TI; Kozik Z; Choudhary JS; Haider S; Pettitt SJ; Tutt ANJ; Lord CJ
    Mol Oncol; 2024 Feb; 18(2):369-385. PubMed ID: 37866880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The ubiquitin ligase FBXW7 targets the centriolar assembly protein HsSAS-6 for degradation and thereby regulates centriole duplication.
    Badarudeen B; Gupta R; Nair SV; Chandrasekharan A; Manna TK
    J Biol Chem; 2020 Apr; 295(14):4428-4437. PubMed ID: 32086376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GSK3-SCF(FBXW7) targets JunB for degradation in G2 to preserve chromatid cohesion before anaphase.
    Pérez-Benavente B; García JL; Rodríguez MS; Pineda-Lucena A; Piechaczyk M; Font de Mora J; Farràs R
    Oncogene; 2013 Apr; 32(17):2189-99. PubMed ID: 22710716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. E3 ubiquitin ligase FBXW7 enhances radiosensitivity of non-small cell lung cancer cells by inhibiting SOX9 regulation of CDKN1A through ubiquitination.
    Zhu H; Wang X; Zhou X; Lu S; Gu G; Liu C
    Lab Invest; 2022 Nov; 102(11):1203-1213. PubMed ID: 35840806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ubiquitylation of unphosphorylated c-myc by novel E3 ligase SCF
    Bajpai S; Jin HR; Mucha B; Diehl JA
    Cancer Biol Ther; 2022 Dec; 23(1):348-357. PubMed ID: 35438057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The SCF-FBXW7 E3 ubiquitin ligase triggers degradation of histone 3 lysine 4 methyltransferase complex component WDR5 to prevent mitotic slippage.
    Hänle-Kreidler S; Richter KT; Hoffmann I
    J Biol Chem; 2022 Dec; 298(12):102703. PubMed ID: 36395886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FBXW7-mediated ERK3 degradation regulates the proliferation of lung cancer cells.
    An HJ; Lee CJ; Lee GE; Choi Y; Jeung D; Chen W; Lee HS; Kang HC; Lee JY; Kim DJ; Choi JS; Cho ES; Choi JS; Cho YY
    Exp Mol Med; 2022 Jan; 54(1):35-46. PubMed ID: 35022544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FBXW7: a critical tumor suppressor of human cancers.
    Yeh CH; Bellon M; Nicot C
    Mol Cancer; 2018 Aug; 17(1):115. PubMed ID: 30086763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Germline variants in tumor suppressor FBXW7 lead to impaired ubiquitination and a neurodevelopmental syndrome.
    Stephenson SEM; Costain G; Blok LER; Silk MA; Nguyen TB; Dong X; Alhuzaimi DE; Dowling JJ; Walker S; Amburgey K; Hayeems RZ; Rodan LH; Schwartz MA; Picker J; Lynch SA; Gupta A; Rasmussen KJ; Schimmenti LA; Klee EW; Niu Z; Agre KE; Chilton I; Chung WK; Revah-Politi A; Au PYB; Griffith C; Racobaldo M; Raas-Rothschild A; Ben Zeev B; Barel O; Moutton S; Morice-Picard F; Carmignac V; Cornaton J; Marle N; Devinsky O; Stimach C; Wechsler SB; Hainline BE; Sapp K; Willems M; Bruel AL; Dias KR; Evans CA; Roscioli T; Sachdev R; Temple SEL; Zhu Y; Baker JJ; Scheffer IE; Gardiner FJ; Schneider AL; Muir AM; Mefford HC; Crunk A; Heise EM; Millan F; Monaghan KG; Person R; Rhodes L; Richards S; Wentzensen IM; Cogné B; Isidor B; Nizon M; Vincent M; Besnard T; Piton A; Marcelis C; Kato K; Koyama N; Ogi T; Goh ES; Richmond C; Amor DJ; Boyce JO; Morgan AT; Hildebrand MS; Kaspi A; Bahlo M; Friðriksdóttir R; Katrínardóttir H; Sulem P; Stefánsson K; Björnsson HT; Mandelstam S; Morleo M; Mariani M; ; Scala M; Accogli A; Torella A; Capra V; Wallis M; Jansen S; Weisfisz Q; de Haan H; Sadedin S; ; Lim SC; White SM; Ascher DB; Schenck A; Lockhart PJ; Christodoulou J; Tan TY
    Am J Hum Genet; 2022 Apr; 109(4):601-617. PubMed ID: 35395208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Role of FBXW7 in Gynecologic Malignancies.
    Di Fiore R; Suleiman S; Drago-Ferrante R; Subbannayya Y; Suleiman S; Vasileva-Slaveva M; Yordanov A; Pentimalli F; Giordano A; Calleja-Agius J
    Cells; 2023 May; 12(10):. PubMed ID: 37408248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FBXW7 is involved in Aurora B degradation.
    Teng CL; Hsieh YC; Phan L; Shin J; Gully C; Velazquez-Torres G; Skerl S; Yeung SC; Hsu SL; Lee MH
    Cell Cycle; 2012 Nov; 11(21):4059-68. PubMed ID: 23095493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclin F/FBXO1 Interacts with HIV-1 Viral Infectivity Factor (Vif) and Restricts Progeny Virion Infectivity by Ubiquitination and Proteasomal Degradation of Vif Protein through SCF
    Augustine T; Chaudhary P; Gupta K; Islam S; Ghosh P; Santra MK; Mitra D
    J Biol Chem; 2017 Mar; 292(13):5349-5363. PubMed ID: 28184007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent insight into the role of FBXW7 as a tumor suppressor.
    Yumimoto K; Nakayama KI
    Semin Cancer Biol; 2020 Dec; 67(Pt 2):1-15. PubMed ID: 32113998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FBXW7 tumor suppressor regulation by dualspecificity tyrosine-regulated kinase 2.
    Jiménez-Izquierdo R; Morrugares R; Suanes-Cobos L; Correa-Sáez A; Garrido-Rodríguez M; Cerero-Tejero L; Khan OM; de la Luna S; Sancho R; Calzado MA
    Cell Death Dis; 2023 Mar; 14(3):202. PubMed ID: 36934104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early growth response-1 is a new substrate of the GSK3β-FBXW7 axis.
    Yin L; Zhang J; Sun Y
    Neoplasia; 2022 Dec; 34():100839. PubMed ID: 36240645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical significance of FBXW7 loss of function in human cancers.
    Fan J; Bellon M; Ju M; Zhao L; Wei M; Fu L; Nicot C
    Mol Cancer; 2022 Mar; 21(1):87. PubMed ID: 35346215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fbxw7 acts as an E3 ubiquitin ligase that targets c-Myb for nemo-like kinase (NLK)-induced degradation.
    Kanei-Ishii C; Nomura T; Takagi T; Watanabe N; Nakayama KI; Ishii S
    J Biol Chem; 2008 Nov; 283(45):30540-8. PubMed ID: 18765672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.